Nanjing, China

Liwei Sun

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Nanjing Genscript Biotech Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liwei Sun. Retrieved from https://idiyas.com/inventor/liwei-sun-ht0rgofw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Liwei Sun: Innovator in Antibody Technology

Introduction

Liwei Sun is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody technologies. His work has the potential to impact various medical applications.

Latest Patents

Liwei Sun holds a patent for "Anti-VHH Domain Antibodies and Use Thereof." This patent showcases his expertise in creating specialized antibodies that can be utilized in therapeutic and diagnostic applications. He has 1 patent to his name, reflecting his innovative approach to biotechnology.

Career Highlights

Liwei Sun is currently employed at Nanjing Genscript Biotech Co., Ltd. His role at this leading biotech company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.

Collaborations

Liwei Sun has worked alongside talented colleagues such as Xijian Qin and Wanyi Wang. Their collaborative efforts have further advanced the research and development of antibody technologies.

Conclusion

Liwei Sun is a notable inventor whose work in antibody technology is paving the way for future innovations in biotechnology. His contributions are essential for the advancement of medical science and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…